189 related articles for article (PubMed ID: 33101610)
1. Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A
Navarro G; Gonzalez A; Campanacci S; Rivas-Santisteban R; Reyes-Resina I; Casajuana-Martin N; Cordomí A; Pardo L; Franco R
Comput Struct Biotechnol J; 2020; 18():2723-2732. PubMed ID: 33101610
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-Like Efficacy of Dopamine D
Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V
Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β
Choi M; Staus DP; Wingler LM; Ahn S; Pani B; Capel WD; Lefkowitz RJ
Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131371
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane.
Khoa ND; Postow M; Danielsson J; Cronstein BN
Mol Pharmacol; 2006 Apr; 69(4):1311-9. PubMed ID: 16385076
[TBL] [Abstract][Full Text] [Related]
5. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
Magnan R; Escrieut C; Gigoux V; De K; Clerc P; Niu F; Azema J; Masri B; Cordomi A; Baltas M; Tikhonova IG; Fourmy D
J Am Chem Soc; 2013 Feb; 135(7):2560-73. PubMed ID: 23323542
[TBL] [Abstract][Full Text] [Related]
6. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
[TBL] [Abstract][Full Text] [Related]
7. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
8. The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias.
Welihinda AA; Kaur M; Greene K; Zhai Y; Amento EP
Cell Signal; 2016 Jun; 28(6):552-60. PubMed ID: 26903141
[TBL] [Abstract][Full Text] [Related]
9. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
10. Characterization of structurally novel G protein biased CB
Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
[TBL] [Abstract][Full Text] [Related]
11. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
[TBL] [Abstract][Full Text] [Related]
12. Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin-biased agonists.
Santos GA; Duarte DA; Parreiras-E-Silva LT; Teixeira FR; Silva-Rocha R; Oliveira EB; Bouvier M; Costa-Neto CM
Front Pharmacol; 2015; 6():131. PubMed ID: 26191004
[TBL] [Abstract][Full Text] [Related]
13. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
14. Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106.
Dickenson JM; Reeder S; Rees B; Alexander S; Kendall D
Eur J Pharmacol; 2003 Aug; 474(1):43-51. PubMed ID: 12909194
[TBL] [Abstract][Full Text] [Related]
15. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
16. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
17. Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2.
Stroth N; Niso M; Colabufo NA; Perrone R; Svenningsson P; Lacivita E; Leopoldo M
Bioorg Med Chem; 2015 Aug; 23(15):4824-4830. PubMed ID: 26081758
[TBL] [Abstract][Full Text] [Related]
18. Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions.
Bruzzese A; Dalton JAR; Giraldo J
PLoS Comput Biol; 2020 Apr; 16(4):e1007818. PubMed ID: 32298258
[TBL] [Abstract][Full Text] [Related]
19. A2a adenosine receptor agonist improves endoplasmic reticulum stress in MIN6 cell line through protein kinase A/ protein kinase B/ Cyclic adenosine monophosphate response element-binding protein/ and Growth Arrest And DNA-Damage-Inducible 34/ eukaryotic Initiation Factor 2α pathways.
Arasi FP; Shahrestanaki MK; Aghaei M
J Cell Physiol; 2019 Jul; 234(7):10500-10511. PubMed ID: 30417358
[TBL] [Abstract][Full Text] [Related]
20. Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay.
Saecker L; Häberlein H; Franken S
Front Pharmacol; 2023; 14():1172551. PubMed ID: 37324481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
